The U.S. Food and Drug Administration says drugmakers have recalled more than a half-million bottles of the blood pressure medication prazosin hydrochloride over concerns it may include a cancer-causing chemical.<\/p>\n
New Jersey-based Teva Pharmaceuticals USA and drugs distributor Amerisource Health Services issued voluntary nationwide recalls<\/a> earlier this month of more than 580,000 bottles of various strengths of prazosine capsules, according to the FDA.<\/p>\n Doctors prescribe prazosin, which relaxes blood vessels, to help lower blood pressure. It also is sometimes prescribed for nightmares and other sleep disturbances caused by post-traumatic stress disorder.<\/p>\n The FDA said in enforcement orders<\/a> posted online that it has given the affected lots of the drug a Class II risk classification because some of the recalled medication may have nitrosamine impurities that are considered potentially cancer causing.<\/p>\n According to the FDA, N-nitrosamine impurities<\/a> are a class of potentially cancer-causing chemicals that can form during manufacture or storage of a drug.<\/p>\n Let’s talk:<\/p>\n Hey there! At TMJ4 News, we’re all about listening to our audience and tackling the stuff that really matters to you. Got a story idea, tip, or just want to chat about this piece? Hit us up using the form below. For more ways to get in touch, head over to tmj4.com\/tips. <\/p>\n It\u2019s about time to watch on your time. Stream local news and weather 24\/7 by searching for \u201cTMJ4\u201d on your device.<\/p>\n Available for download on Roku, Apple TV, Amazon Fire TV, and more.<\/a><\/p>\n